Monovision for the Treatment of Diplopia
Monovision for the Treatment of Diplopia
PURPOSE:

 The purpose of this study is to quantitatively assess the efficacy of monovision correction
 in the treatment of acquired small angle binocular diplopia in adult patients.

 METHOD:

 Twenty patients with symptomatic diplopia were enrolled in a prospective treatment trial. All
 had stable deviations of 10 prism diopters or less for over three months. Each received
 monovision spectacles and/ or contact lenses with distance correction in the dominant eye.
 Half received a +3.00 diopter (D) add and the others received +2.50 D. The validated and
 standardized Diplopia Questionnaire and Amblyopia and Strabismus Questionnaire (ASQE) were
 used to quantify the efficacy of monovision correction for diplopia by measuring the
 functional impact on vision-specific quality of life.
Inclusion Criteria:

 -  Strabismic Deviation less than 12 Prism Diopters

 Exclusion Criteria:

 -  Inability to sign informed consent